CD19 and B-cell acute lymphoblastic leukemia: The mechanism of CAR T cells involves the adoptive transfer of modified T cells, i.e., chimeric antigen receptor (CAR) T cells intended towards the cluster of differentiation 19 (CD19), which is currently authorized to cure patients with advanced B cell lymphoma and refractory B cell acute lymphoblastic leukemia-ALL [12].